Literature DB >> 22672700

Infection complications in an unselected cohort of patients with multiple myeloma treated with lenalidomide combinations.

Tommaso Caravita, Massimo Offidani, Agostina Siniscalchi, Silvia Gentili, Patrizia Caraffa, Alessio Perrotti, Paolo de Fabritiis, Pietro Leoni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22672700     DOI： 10.1111/j.1600-0609.2012.01814.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN： 0902-4441            Impact factor:   2.997


× No keyword cloud information.
  4 in total

1.  Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients.

Authors:  Cecilie Blimark; Erik Holmberg; Ulf-Henrik Mellqvist; Ola Landgren; Magnus Björkholm; Malin Hultcrantz; Christian Kjellander; Ingemar Turesson; Sigurdur Y Kristinsson
Journal:  Haematologica       Date:  2014-10-24       Impact factor: 9.941

2.  Infections in patients with multiple myeloma treated with conventional chemotherapy: a single-center, 10-year experience in Pakistan.

Authors:  Mohammad Faizan Zahid; Natasha Ali; Myra Nasir; Maria Haider Baig; Mustafa Iftikhar; Syed Usman Bin Mahmood; Arhama Malik; Sara Atif; Mohammad Asim Beg
Journal:  Hematol Transfus Cell Ther       Date:  2019-06-14

3.  Development of a Risk Assessment Model for Early Grade ≥ 3 Infection During the First 3 Months in Patients Newly Diagnosed With Multiple Myeloma Based on a Multicenter, Real-World Analysis in China.

Authors:  Yufeng Shang; Weida Wang; Yuxing Liang; Natasha Mupeta Kaweme; Qian Wang; Minghui Liu; Xiaoqin Chen; Zhongjun Xia; Fuling Zhou
Journal:  Front Oncol       Date:  2022-03-17       Impact factor: 6.244

4.  Efficacy and tolerability of bendamustine, bortezomib and dexamethasone in patients with relapsed-refractory multiple myeloma: a phase II study.

Authors:  M Offidani; L Corvatta; L Maracci; A M Liberati; S Ballanti; I Attolico; P Caraffa; F Alesiani; T Caravita di Toritto; S Gentili; P Tosi; M Brunori; D Derudas; A Ledda; A Gozzetti; C Cellini; L Malerba; A Mele; A Andriani; S Galimberti; P Mondello; S Pulini; U Coppetelli; P Fraticelli; A Olivieri; P Leoni
Journal:  Blood Cancer J       Date:  2013-11-22       Impact factor: 11.037
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.